Shares of Owens & Minor, Inc. (NYSE:OMI) have been assigned a consensus target price of $11.60 by analysts, reflecting a “Hold” recommendation from five rating firms currently monitoring the stock. This rating includes one sell recommendation, two holds, and two buy recommendations, according to data from Marketbeat.
Analysts have recently updated their assessments and issued varied price objectives. Notably, Citigroup lowered its target for Owens & Minor from $13.00 to $11.00, while maintaining a “buy” rating in a report dated April 17, 2024. Conversely, Robert W. Baird raised its price target from $9.00 to $10.00, assigning the stock a “neutral” rating in a report released on June 6, 2024.
Current Stock Performance
As of Wednesday, Owens & Minor shares opened at $8.12. The company boasts a market capitalization of $627.27 million and a price-to-earnings ratio of -1.71, indicating some financial challenges. The stock has a 50-day moving average of $7.64 and a 200-day moving average of $9.05. Financial ratios reveal a current ratio of 1.13, a quick ratio of 0.41, and a debt-to-equity ratio of 3.32. Over the past year, Owens & Minor’s stock has fluctuated, hitting a low of $6.07 and a high of $16.98.
The company recently reported its quarterly earnings results on May 10, 2024. Owens & Minor achieved an earnings per share (EPS) of $0.23, surpassing analysts’ expectations of $0.20 by $0.03. This represents an improvement from the previous year’s EPS of $0.19. Additionally, the company noted a 0.7% increase in quarterly revenue compared to the same period last year, although it faced a negative net margin of 3.41% and reported a return on equity of 17.09%.
Overview of Owens & Minor
Owens & Minor, Inc. specializes in healthcare solutions that encompass product manufacturing, delivery, home health supply, and perioperative services aimed at supporting care from the hospital to home. The company is structured into two primary segments: Products and Healthcare Services, and Patient Direct.
Looking ahead, analysts forecast that Owens & Minor will achieve an EPS of 1.51 for the current fiscal year. With ongoing developments and a mixed outlook from financial analysts, the company remains a focal point for investors in the healthcare sector.
For those interested in keeping up with Owens & Minor and related companies, MarketBeat offers a free daily email newsletter providing concise summaries of the latest news and analyst ratings.
